Skip to Main Content

Author Details

Minjae Yoo
University of Colorado Anschutz Medical Campus
2011
15
10
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33795352Novel Human-Derived <i>RET</i> Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling.Mol Pharmacol2021
33795352Novel Human-Derived <i>RET</i> Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling.Mol Pharmacol2021
29650251Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.Comput Methods Programs Biomed2019
31751239Unsupervised Deep Contrast Enhancement with Power Constraint for OLED Displays.IEEE Trans Image Process2019
29650251Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.Comput Methods Programs Biomed2019
31751239Unsupervised Deep Contrast Enhancement with Power Constraint for OLED Displays.IEEE Trans Image Process2019
29126216PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology.Nucleic Acids Res2018
29765977Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine.Int J Genomics2018
29126216PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology.Nucleic Acids Res2018
29697364IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.BMC Med Genomics2018
29697364IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.BMC Med Genomics2018
29765977Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine.Int J Genomics2018
28500237Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.Mol Cancer Ther2017
28500237Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.Mol Cancer Ther2017
27322211Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.Oncotarget2016
27322211Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.Oncotarget2016
27631620Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.Assay Drug Dev Technol2016
27631620Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.Assay Drug Dev Technol2016
25990557DSigDB: drug signatures database for gene set analysis.Bioinformatics2015
25990557DSigDB: drug signatures database for gene set analysis.Bioinformatics2015
26206305Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.Bioinformatics2015
26681397An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer.BMC Genomics2015
26681397An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer.BMC Genomics2015
26206305Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.Bioinformatics2015
24812339Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.Bioinformatics2014
24812339Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.Bioinformatics2014
24060470K-Map: connecting kinases with therapeutics for drug repurposing and development.Hum Genomics2013
24060470K-Map: connecting kinases with therapeutics for drug repurposing and development.Hum Genomics2013
21345311SABA (secondary structure assignment program based on only alpha carbons): a novel pseudo center geometrical criterion for accurate assignment of protein secondary structures.BMB Rep2011
21345311SABA (secondary structure assignment program based on only alpha carbons): a novel pseudo center geometrical criterion for accurate assignment of protein secondary structures.BMB Rep2011
  • 1 - 30 of 30

Recommended Authors

College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 0
University of Helsinki
Career Start Year 2016
Number of shared co-authors 0
University of Helsinki
Career Start Year 2016
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 2015
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 2014
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health Sciences University
Career Start Year 2014
Number of shared co-authors 0
Moffitt Cancer Center
Career Start Year 2014
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Helsinki Institute for Information Technology (HIIT), Aalto University
Career Start Year 2012
Number of shared co-authors 0
The Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 0
The University of Texas Health Science Center at Houston
Career Start Year 2012
Number of shared co-authors 0
University of Georgia
Career Start Year 2011
Number of shared co-authors 1
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Shanghai Jiao Tong University
Career Start Year 2009
Number of shared co-authors 2
Bio-X Institutes, Shanghai Jiao Tong University
Career Start Year 2008
Number of shared co-authors 0
Xiamen University
Career Start Year 2008
Number of shared co-authors 0
Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht
Career Start Year 2007
Number of shared co-authors 0
University of Helsinki
Career Start Year 2007
Number of shared co-authors 0
College of Medicine, Hanyang University
Career Start Year 2006
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Korea Advanced Institute of Science and Technology
Career Start Year 2004
Number of shared co-authors 0
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 1
Korea University
Career Start Year 2000
Number of shared co-authors 3
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 2
Institute for Data Science and Computing, University of Miami
Career Start Year 1998
Number of shared co-authors 1
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0

Collaborators

Huntsman Cancer Institute, The University of Utah
Co-authored papers 13
Korea University
Co-authored papers 7
Sungkyunkwan University School of Medicine
Co-authored papers 6
Co-authored papers 2
Binzhou Medical University Hospital
Co-authored papers 1
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 1
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Korea University College of Medicine
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Co-authored papers 1
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers 1
Duke University
Co-authored papers 1